Skip to content

TG THERAPEUTICS, INC.: 10-Q/A filed 2012-09-07

What TG THERAPEUTICS, INC. reported in its quarterly report amendment filed 2012-09-07 (fiscal Q2 2012): 25 published measures, 83 facts as tagged in accession 0001144204-12-050166.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2012-09-07
Fiscal period
fiscal Q2 2012
Accession
0001144204-12-050166 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TG THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-3026,529,557USD
At 2011-12-3115,907,258USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-306,744,147USD
At 2011-12-316,271,056USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-3011,015,683USD
At 2011-12-319,624,521USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-3020,367,079USD
At 2011-12-319,748,491USD
At 2011-06-300USD
At 2011-03-310USD
At 2010-12-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-1,894,653USD91
2012-01-01 to 2012-06-30-12,150,743USD182
2011-04-01 to 2012-06-30-13,003,817USD457
2011-04-01 to 2011-06-30-282,105USD91
2011-01-01 to 2011-06-30-282,105USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-1,361,419USD182
2011-04-01 to 2012-06-30-1,447,996USD457
2011-01-01 to 2011-06-300USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-06-301,399USD182
2011-04-01 to 2012-06-301,399USD457
2011-01-01 to 2011-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-06-3011,981,406USD182
2011-04-01 to 2012-06-3021,806,088USD457
2011-01-01 to 2011-06-300USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-06-30-1,399USD182
2011-04-01 to 2012-06-308,987USD457
2011-01-01 to 2011-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-06-301,399USD
At 2011-12-310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,171,991USD91
2012-01-01 to 2012-06-301,360,500USD182
2011-04-01 to 2012-06-301,446,994USD457

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-3,104,930USD91
2012-01-01 to 2012-06-30-20,490,284USD182
2011-04-01 to 2012-06-30-21,372,258USD457
2011-04-01 to 2011-06-30-297,000USD91
2011-01-01 to 2011-06-30-297,000USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-3020,456,567USD
At 2011-12-319,835,667USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-04-01 to 2012-06-30228,109USD91
2012-01-01 to 2012-06-30448,258USD182
2011-04-01 to 2012-06-30455,355USD457
2011-04-01 to 2011-06-300USD91
2011-01-01 to 2011-06-300USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-06-302,349,047USD
At 2011-12-311,606,359USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2012-06-30629,752USD
At 2011-12-31629,752USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-04-01 to 2012-06-303,104,930USD91
2012-01-01 to 2012-06-3020,490,284USD182
2011-04-01 to 2012-06-3021,372,258USD457
2011-04-01 to 2011-06-30297,000USD91
2011-01-01 to 2011-06-30297,000USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,646,094USD91
2012-01-01 to 2012-06-3018,387,447USD182
2011-04-01 to 2012-06-3018,714,730USD457
2011-04-01 to 2011-06-30297,000USD91
2011-01-01 to 2011-06-30297,000USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-06-3018,053,995shares
At 2011-12-315,061,399shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-3024,001,440USD
At 2011-12-3110,472,115USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-06-3019,785,410USD
At 2011-12-319,636,202USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-2,574,159USD91
2012-01-01 to 2012-06-30-19,970,697USD182
2011-04-01 to 2012-06-30-20,859,768USD457
2011-04-01 to 2011-06-30-297,000USD91
2011-01-01 to 2011-06-30-297,000USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-301,458,836USD91
2012-01-01 to 2012-06-302,102,837USD182
2011-04-01 to 2012-06-302,657,528USD457
2011-04-01 to 2011-06-300USD91
2011-01-01 to 2011-06-300USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-04-01 to 2012-06-30530,771USD91
2012-01-01 to 2012-06-30519,587USD182
2011-04-01 to 2012-06-30512,490USD457
2011-04-01 to 2011-06-300USD91
2011-01-01 to 2011-06-300USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-06-300USD182
2011-04-01 to 2012-06-309,824,682USD457
2011-01-01 to 2011-06-300USD181

Inspect the source

Entity
TG THERAPEUTICS, INC. / CIK 0001001316
Captured
2026-09-20T05:11:16.212Z
SEC response SHA-256
153d276440c1903144d2ca193676af4b7014428a3e4b5524efe33528427880b3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001001316.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))